$EXPO

James Bradley A sold $115K of EXPO

James Bradley A (Group Vice President) sold 2,000 shares of EXPONENT INC (EXPO) at $57.46 ($0.11M total) on 2026-05-26.

Original reporting
SEC EDGAR · James Bradley A
Published May 27, 2026, 4:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 27, 2026, 4:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$EXPO
Bearish
medium confidence
Mentioned
$EXPO
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EXPOBearishMed
01

Why it matters

Traders may react to insider selling as a sentiment input, but the filing lacks any fundamental update (no earnings, guidance, deal, or regulatory action).

02

Market read

Expect a modest, short-term sentiment effect for EXPO around the disclosure; longer-term direction likely depends on upcoming fundamentals rather than this transaction.

03

What to watch

No 10b5-1 plan is cited, but Form 4s often omit intent; also, the post-trade holdings remain substantial (1,105 shares), suggesting no full exit.

Relevance 7/10Timing: Immediate (filed 2026-05-27; trade impact most likely around the disclosure window).

Background

The article is a SEC Form 4 insider transaction disclosure for Exponent Inc, showing an officer/direct sale of company shares.

Company-level read

Ticker impact

$EXPOBearishMedium confidence
Context

Exponent Inc (EXPO) disclosed an officer open-market sale: 2,000 shares sold at $57.4650 on 2026-05-26 via SEC Form 4.

Expected impact

Likely mild, short-lived downside bias around the filing date; no clear fundamental catalyst indicated.

Evidence & confidence

This is an ownership-change disclosure (Form 4) with no accompanying operational or financial news; absence of a stated 10b5-1 plan increases interpretation risk but does not prove bearish fundamentals.

Market effects

Limited read-across; insider Form 4s are usually company-specific sentiment signals rather than sector catalysts.

None indicated; filing is US SEC EDGAR with no regional macro linkage.

None indicated; no international deal/regulatory/earnings content.

Counterpoint

The sale could be routine diversification or tax-related; without context, it may not reflect a change in outlook.

Key entities

  • Exponent Inc

    Subject of the Form 4 insider sale by James Bradley A (Group Vice President).

  • James Bradley A

    Exponent officer who sold 2,000 shares at $57.4650 on 2026-05-26.

Related articles

$EXPOMedAI 8/10

Exponent (EXPO) Q2 2026 Earnings Call Transcript

Exponent, Inc. (EXPO) reported Q2 2026 net revenues of $148.9 million, up 12% from $132.9 million a year earlier, and net income of $29.4 million, up 11%. Diluted EPS was $0.60. Management raised FY 2026 revenue guidance to 9% to 10% growth and EBITDA margin to 27.8% to 28.1%, and authorized an additional $50 million for share repurchases.

$EXPOMedAI 8/10

Exponent Q2 Earnings Call Highlights

Exponent (NASDAQ:EXPO) reported Q2 EBITDA up 16% to $42.7 million, with EBITDA margin at 28.7% of net revenue versus 27.8% a year earlier. Billable hours rose 8% to about 390,000 and utilization increased to 74%. The company repurchased $67.4 million of stock and paid $14.8 million in dividends. It raised 2026 outlook for net revenue growth of 9% to 10%.